Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 4, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mike Matson Reiterated (AORT) at Strong Buy and Held Target at $26 on, Aug 4th, 2023
Mike Matson of Needham, Reiterated "Artivion, Inc." (AORT) at Strong Buy and Held Target at $26 on, Aug 4th, 2023.
Mike has made no other calls on AORT in the last 4 months.
There is 1 other peer that has a rating on AORT. Out of the 1 peers that are also analyzing AORT, all agrees with Mike's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $15 on, Monday, May 8th, 2023
